Coeliac Disease Trial, Recruiting NCT06191432 Sponsor: University of Palermo Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT06191432
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old.
  • Your blood tests show no signs of celiac disease-related antibodies (specific proteins the immune system makes in response to gluten).
  • You do not have damage to the lining of your small intestine (confirm with trial site), especially if you carry certain genetic markers linked to celiac disease (HLA-DQ2 and/or DQ8).
  • You have tested negative for a wheat allergy, based on a skin prick test and/or a blood test measuring allergy-related proteins.

Who may not be able to join:

  • You are under 18 or over 65 years old.
  • You are already avoiding gluten or wheat in your diet and are not willing to reintroduce it for testing purposes before the trial begins.
  • You are pregnant.
  • You have issues with alcohol or drug misuse.
  • You have an active infection such as Helicobacter pylori (a stomach bacteria) or other bacterial or parasitic infections.
  • You have been diagnosed with a long-term inflammatory bowel condition, serious liver disease, a nervous system condition, a major psychiatric disorder, or an immune system problem that affects your ability to be physically active.
  • You have been diagnosed with cancer.
  • You are currently receiving chemotherapy or radiotherapy treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antonio Carroccio, MD, University of Palermo

Phone: 00390916554815

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Palermo
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
31 July 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Evaluation of gastrointestinal symptoms evoked by dietary exposition to Triticum Monococcum and Triticum Aestivum; Evaluation of extraintestinal symptoms evoked by dietary exposition to Triticum Monococcum and Triticum Aestivum; Evaluation of quality of life modification evoked by dietary exposition to Triticum Monococcum and Triticum Aestivum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov